MAPT and Parkinson disease: A combination of α-syn species, lysosomal enzymes, markers of amyloid and Tau pathology, and NfL in the CSF and blood have been reported as potential diagnostic and prognostic biomarkers of PD, reflecting the dynamic course of its pathophysiology [4].